In astrocytic tumors, Cx36 increases its levels inside tumor cells but decreases its expression in the environment depending on the tumor grade [134], which makes Cx36 a useful biomarker for tumor diagnosis and prediction of neoplasm progression. Here, GJD2 is linked to astrocytic tumor.